These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8529436)
1. In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Sidwell RW; Bailey KW; Wong MH; Huffman JH Chemotherapy; 1995; 41(6):455-61. PubMed ID: 8529436 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250 [TBL] [Abstract][Full Text] [Related]
3. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses. Lee MG; Kim KH; Park KY; Kim JS Arch Virol; 1996; 141(10):1979-89. PubMed ID: 8920829 [TBL] [Abstract][Full Text] [Related]
5. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors. Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681 [TBL] [Abstract][Full Text] [Related]
6. The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo. Deryabin PG; Galegov GA; Konstantinova ID; Muzyka IS; Miroshnikov AI; L'vov DK Dokl Biochem Biophys; 2014 Mar; 455(1):80-3. PubMed ID: 24795106 [No Abstract] [Full Text] [Related]
7. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Ryan DM; Ticehurst J; Dempsey MH; Penn CR Antimicrob Agents Chemother; 1994 Oct; 38(10):2270-5. PubMed ID: 7840556 [TBL] [Abstract][Full Text] [Related]
8. The relative potencies of anti-influenza compounds. Tisdale M; Bauer DJ Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of influenza virus replication by plant-derived isoquercetin. Kim Y; Narayanan S; Chang KO Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184 [TBL] [Abstract][Full Text] [Related]
10. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice. Sidwell RW; Huffman JH; Bailey KW; Wong MH; Nimrod A; Panet A Antimicrob Agents Chemother; 1996 Nov; 40(11):2626-31. PubMed ID: 8913477 [TBL] [Abstract][Full Text] [Related]
12. Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine. Smee DF; Wandersee MK; Wong MH; Bailey KW; Sidwell RW Antivir Chem Chemother; 2004 Sep; 15(5):261-8. PubMed ID: 15535048 [TBL] [Abstract][Full Text] [Related]
13. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Sidwell RW; Huffman JH; Gilbert J; Moscon B; Pedersen G; Burger R; Warren RP Antimicrob Agents Chemother; 1992 Feb; 36(2):473-6. PubMed ID: 1605614 [TBL] [Abstract][Full Text] [Related]
15. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice. Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596 [TBL] [Abstract][Full Text] [Related]
16. Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. Walker JS; Stephen EL; Spertzel RO J Infect Dis; 1976 Jun; 133 Suppl():A140-4. PubMed ID: 932501 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. Nguyen JT; Smee DF; Barnard DL; Julander JG; Gross M; de Jong MD; Went GT PLoS One; 2012; 7(1):e31006. PubMed ID: 22292088 [TBL] [Abstract][Full Text] [Related]
18. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals. Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224 [TBL] [Abstract][Full Text] [Related]
19. [In vitro and in vivo anti-influenza virus activity of ribavirin injection]. Gao RM; Li XQ; He WY; Jiang JD; Li YH Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521 [TBL] [Abstract][Full Text] [Related]
20. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses. Smee DF; Wong MH; Bailey KW; Sidwell RW Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]